Vincristine by continuous infusion in refractory breast cancer: a phase II study

Eighteen patients with advanced refractory breast carcinoma were treated with vincristine (VCR), 0.5 mg I.V. bolus followed by continuous I.V. infusions of 0.25 mg/m2/day for 5 days every 3 weeks. The daily dose of VCR was infused in 1000 ml D5W to which was added hydrocortisone 50 mg and heparin 30...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of clinical oncology 1983-10, Vol.6 (5), p.529-532
Hauptverfasser:	HOPKINS, J. O, JACKSON, D. V. JR, WHITE, D. R, MUSS, H. B, COOPER, M. R, STUART, J. J, SPURR, C. L, BRADLEY WELLS, H, RICHARDS, F. II
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic agents Biological and medical sciences Breast Neoplasms - drug therapy Chemotherapy Drug Administration Schedule Drug Evaluation Female Humans Infusions, Parenteral Medical sciences Pharmacology. Drug treatments Vincristine - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!